Surgalign Holdings, Inc. Appoints Paul Lewicki, PhD to Board of Directors
November 23 2020 - 9:00AM
Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine
company focused on advancing spine surgery including through the
application of digital technologies to improve patient outcomes,
today announced the appointment of Paul Lewicki, PhD as a member of
its board of directors. With Dr. Lewicki’s appointment the
Surgalign Board now consists of nine directors.
Prior to its acquisition by Surgalign, Dr. Lewicki served as
President of Holo Surgical, Inc. where he played a significant role
in developing the revolutionary Augmented Reality and Artificial
Intelligence platform. He is a cognitive scientist,
entrepreneur and investor and a former professor of cognitive
psychology at the University of Tulsa, where he established the
Nonconscious Information Processing Laboratory funded by multiple
grants from the NSF and NIH. He was among the first
scientists to publish evidence that the advanced expertise,
acquired by humans from experience, involves multivariate and
highly-interactive patterns in data, which are much more complex
than what humans are able to consciously articulate or even
communicate. This approach became popular and quickly adopted by
the corporate world as so-called “predictive data mining” – making
computers derive from Big Data more complex patterns than what
humans can understand, and then use these patterns to make new
predictions.
He started StatSoft, a company that pioneered commercial
applications of data mining, and rapidly became a large developer
of data mining solutions for all industries, with offices in 30
countries and over 1 million accounts. He was the CEO and largest
shareholder when StatSoft was acquired by Dell in 2014
“Dr. Lewicki is a thought leader in predictive analytics and has
a deep passion for the use of artificial intelligence to promote
the general welfare by accelerating technology progress in the area
of medicine,” Terry Rich, President and Chief Executive Officer of
Surgalign Holdings. “We have a shared vision of the promise
of digital surgery to improve patient outcomes and look forward to
Paul’s contribution to the achievement of our strategic
vision.”
“I am excited to be joining Surgalign’s board of directors and
leveraging my expertise in predictive analytics and digital
technology to help the company advance the standard of spine care
by reimagining what is possible through integrated intelligent
technology,” stated Dr. Lewicki.About Surgalign Holdings,
Inc.
Surgalign Holdings, Inc. is a global medical technology company
advancing the science of spine care, focused on delivering
innovative solutions that drive superior clinical and economic
outcomes. The company is building off a legacy of high quality and
differentiated products and continues to invest in clinically
validated innovation to deliver better surgical outcomes and
improve patient’s lives. Surgalign markets products
throughout the United States and in more than 50 countries
worldwide through an expanding network of top independent
distributors. Surgalign, a member of AdvaMed, is
headquartered in Deerfield, IL, with commercial, innovation and
design centers in San Diego, CA, Marquette, MI, and Wurmlingen,
Germany. Learn more at www.surgalign.com and connect on LinkedIn
and Twitter.
Forward Looking Statement
This communication contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our industry,
our management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks and uncertainties,
including the risks described in public filings with the U.S.
Securities and Exchange Commission (SEC). Our actual results may
differ materially from the anticipated results reflected in these
forward-looking statements. Copies of the company's SEC filings may
be obtained by contacting the company or by visiting Surgalign's
website at www.surgalign.com or the SEC's website
at www.sec.gov
Jonathon SingerInvestor and Media Contactjsinger@surgalign.com+1
224 303 4651
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Sep 2023 to Sep 2024